Covalent adduct formation between the plasmalogen-derived modification product 2-chlorohexadecanal and phloretin.

Biochem Pharmacol · 2015 · PMC4321883 · PMID 25576489

Europe PMC DOI

hedged sentence

0.0619

closest p · 1.2× alpha

0.0619

boldest claim

The sentences

did not reach statistical significancep = 0.0619so close (0.05 < p ≤ 0.1)

5 C), although the difference between 2-ClHDA plus phloretin and adduct-treated cells did not reach statistical significance ( p = 0.0619).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.